Catalyst Biosciences, Inc. Banner Image

Catalyst Biosciences, Inc.

  • Ticker CBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Catalyst Biosciences, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and complement-mediated disorders. Their protease engineering platform includes two late-stage clinical programs in hemophilia; a research program on engineering of subcutaneous (SQ) complement inhibitors; and a partnered preclinical development program with BiogenMore for dry age-related macular degeneration (AMD). The product candidates generated by their protease engineering platform have improved functionality and potency that allow for: SQ administration of recombinant coagulation factors and complement inhibitors; low-dose, high activity gene therapy constructs; and less frequently dosed intravitreal therapeutics.
4.8 / 5.0 (156)

Catalyst Biosciences, Inc. reports have an aggregate usefulness score of 4.8 based on 156 reviews.

Catalyst Biosciences, Inc.

Most Recent Annual Report

Catalyst Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Catalyst Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!